Long-term follow-up of psilocybin-facilitated smoking cessation

Abstract

Background: A recent open-label pilot study (N= 15) found that two to three moderate to high doses (20 and 30 mg/70 kg) of the serotonin 2A receptor agonist, psilocybin, in combination with cognitive behavioral therapy (CBT) for smoking cessation, resulted in substantially …